Open main menu
Home
Random
Recent changes
Special pages
Community portal
Preferences
About Wikipedia
Disclaimers
Incubator escapee wiki
Search
User menu
Talk
Dark mode
Contributions
Create account
Log in
Editing
Radiosurgery
(section)
Warning:
You are not logged in. Your IP address will be publicly visible if you make any edits. If you
log in
or
create an account
, your edits will be attributed to your username, along with other benefits.
Anti-spam check. Do
not
fill this in!
==Risks== ''[[The New York Times]]'' reported in December 2010 that radiation overdoses had occurred with the linear accelerator method of radiosurgery, due in large part to inadequate safeguards in equipment retrofitted for stereotactic radiosurgery.<ref>{{cite news | url = https://www.nytimes.com/2010/12/29/health/29radiation.html | title = A Pinpoint Beam Strays Invisibly, Harming Instead of Healing | work = [[The New York Times]] | date = 2010-12-28}}</ref> In the U.S. the [[Food and Drug Administration]] (FDA) regulates these devices, whereas the Gamma Knife is regulated by the [[Nuclear Regulatory Commission]]. This is evidence that [[Cancer immunotherapy|immunotherapy]] may be useful for treatment of radiation necrosis following stereotactic radiotherapy.<ref name="pmid28368903">{{cite journal | vauthors = Kaidar-Person O, Zagar TM, Deal A, Moschos SJ, Ewend MG, Sasaki-Adams D, Lee CB, Collichio FA, Fried D, Marks LB, Chera BS | display-authors = 6 | title = The incidence of radiation necrosis following stereotactic radiotherapy for melanoma brain metastases: the potential impact of immunotherapy | journal = Anti-Cancer Drugs | volume = 28 | issue = 6 | pages = 669β675 | date = July 2017 | pmid = 28368903 | doi = 10.1097/CAD.0000000000000497 | s2cid = 3560210 }}</ref>
Edit summary
(Briefly describe your changes)
By publishing changes, you agree to the
Terms of Use
, and you irrevocably agree to release your contribution under the
CC BY-SA 4.0 License
and the
GFDL
. You agree that a hyperlink or URL is sufficient attribution under the Creative Commons license.
Cancel
Editing help
(opens in new window)